Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

377 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Breast cancer cell contamination of blood stem cell products in patients with metastatic breast cancer: predictors and clinical relevance.
Pecora AL, Lazarus HM, Jennis AA, Preti RA, Goldberg SL, Rowley SD, Cantwell S, Cooper BW, Copelan EA, Herzig RH, Meagher R, Kennedy MJ, Akard LR, Jansen J, Ross A, Prilutskaya M, Glassco J, Kahn D, Moss TJ. Pecora AL, et al. Among authors: kennedy mj. Biol Blood Marrow Transplant. 2002;8(10):536-43. doi: 10.1053/bbmt.2002.v8.pm12434948. Biol Blood Marrow Transplant. 2002. PMID: 12434948 Free article.
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer.
Rowlings PA, Williams SF, Antman KH, Fields KK, Fay JW, Reed E, Pelz CJ, Klein JP, Sobocinski KA, Kennedy MJ, Freytes CO, McCarthy PL Jr, Herzig RH, Stadtmauer EA, Lazarus HM, Pecora AL, Bitran JD, Wolff SN, Gale RP, Armitage JO, Vaughan WP, Spitzer G, Horowitz MM. Rowlings PA, et al. Among authors: kennedy mj. JAMA. 1999 Oct 13;282(14):1335-43. doi: 10.1001/jama.282.14.1335. JAMA. 1999. PMID: 10527180
Similar breast cancer cell contamination of single-day peripheral-blood progenitor-cell collections obtained after priming with hematopoietic growth factor alone or after cyclophosphamide followed by growth factor.
Passos-Coelho JL, Ross AA, Kahn DJ, Moss TJ, Davis JM, Huelskamp AM, Noga SJ, Davidson NE, Kennedy MJ. Passos-Coelho JL, et al. Among authors: kennedy mj. J Clin Oncol. 1996 Sep;14(9):2569-75. doi: 10.1200/JCO.1996.14.9.2569. J Clin Oncol. 1996. PMID: 8823337
Comparative analysis of breast cancer contamination in mobilized and nonmobilized hematopoietic grafts.
Ross AA, Layton TJ, Ostrander AB, Passos-Coelho JL, Davis JM, Huelskamp AM, Noga SJ, Davidson NE, Kennedy MJ, Cooper BW, Gerson SL, Lazarus HM, Holland K, Gluck S, Moss TJ, Kaubish A, Vahdat L, Antman K. Ross AA, et al. Among authors: kennedy mj. J Hematother. 1996 Oct;5(5):549-52. doi: 10.1089/scd.1.1996.5.549. J Hematother. 1996. PMID: 8938527 No abstract available.
High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America.
Antman KH, Rowlings PA, Vaughan WP, Pelz CJ, Fay JW, Fields KK, Freytes CO, Gale RP, Hillner BE, Holland HK, Kennedy MJ, Klein JP, Lazarus HM, McCarthy PL Jr, Saez R, Spitzer G, Stadtmauer EA, Williams SF, Wolff S, Sobocinski KA, Armitage JO, Horowitz MM. Antman KH, et al. Among authors: kennedy mj. J Clin Oncol. 1997 May;15(5):1870-9. doi: 10.1200/JCO.1997.15.5.1870. J Clin Oncol. 1997. PMID: 9164197
Dose intensive therapy in breast cancer.
Antman K, Corringham R, de Vries E, Elfenbein G, Gianni AM, Gisselbrecht C, Herzig R, Juttner C, Kaizer H, Kennedy MJ, et al. Antman K, et al. Among authors: kennedy mj. Bone Marrow Transplant. 1992;10 Suppl 1:67-73. Bone Marrow Transplant. 1992. PMID: 1355686 Review. No abstract available.
377 results